Amphastar Pharmaceuticals was analyzed using value investing metrics on July 23, 2025.
2 reports, 1 independent
Updated Jul 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amphastar Pharmaceuticals was analyzed using value investing metrics on July 23, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amphastar Pharmaceuticals
publicly traded American pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksShould Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find grea
- Unknown outlet